S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
NYSE:CRHC

Cohn Robbins (CRHC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$8.37
$10.01
52-Week Range
N/A
Volume
32 shs
Average Volume
562,596 shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CRHC stock logo

About Cohn Robbins Stock (NYSE:CRHC)

Cohn Robbins Holdings Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was formerly known as CSR Acquisition Corp. Cohn Robbins Holdings Corp. was incorporated in 2020 and is based in Wilmington, Delaware.


CRHC Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Ami S. Bhavsar-Cohn
Aaron Cohn Middle School
Dr. Bradley E. Cohn
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Emily Cohn
Dr. Jamie D. Cohn
Jane Cohn-Mannino
See More Headlines
Receive CRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cohn Robbins and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$35.90 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.63) per share

Miscellaneous

Free Float
N/A
Market Cap
$1.04 billion
Optionable
Not Optionable
Beta
0.02
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NYSE:CRHC) was last updated on 2/27/2024 by MarketBeat.com Staff